Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone

被引:20
作者
Ahn, Hye Sook
Kim, Sung Eun
Jang, Hyun-Jong
Kim, Myung-Jun
Rhie, Duck-Joo
Yoon, Shin-Hee
Jo, Yang-Hyeok
Kim, Myung-Suk
Sung, Ki-Wug
Kim, Seong Yun
Hahn, Sang June
机构
[1] Catholic Univ Korea, Coll Med, Med Res Ctr, Dept Physiol, Seoul 137701, South Korea
[2] Catholic Univ, Coll Med, Med Res Ctr, Dept Pharmacol, Seoul 137701, South Korea
关键词
thiazolidinedione; voltage-gated K+ channel; insulin sensitizer;
D O I
10.1007/s00210-006-0118-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of rosiglitazone and troglitazone were examined on cloned Kv1.3 channels stably expressed in Chinese hamster ovary cells using the whole-cell configuration of the patch-clamp technique. Rosiglitazone decreased the Kv1.3 currents and accelerated the decay rate of current inactivation in a concentration-dependent manner with an IC50 of 18.6 mu M. These effects were reversible after washout of the drug. Troglitazone caused the block of Kv1.3 with a similar pattern but was five times more potent than rosiglitazone with an IC50 of 3.5 mu M. The block of Kv1.3 by rosiglitazone and troglitazone was voltage-dependent at a membrane potential coinciding with the activation of the channels. Both drugs decreased the tail current amplitude and slowed the deactivation process of Kv1.3, resulting in a tail crossover phenomenon. These results indicate that rosiglitazone and troglitazone block the open state of Kv1.3 channels, suggesting that it is an important pharmacological target for rosiglitazone as a potent blocker of Kv1.3 channels.
引用
收藏
页码:305 / 309
页数:5
相关论文
共 19 条
[1]   Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J].
Barroso, I ;
Gurnell, M ;
Crowley, VEF ;
Agostini, M ;
Schwabe, JW ;
Soos, MA ;
Maslen, GL ;
Williams, TDM ;
Lewis, H ;
Schafer, AJ ;
Chatterjee, VKK ;
O'Rahilly, S .
NATURE, 1999, 402 (6764) :880-883
[2]   Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice [J].
Berger, J ;
Bailey, P ;
Biswas, C ;
Cullinan, CA ;
Doebber, TW ;
Hayes, NS ;
Saperstein, R ;
Smith, RG ;
Leibowitz, MD .
ENDOCRINOLOGY, 1996, 137 (10) :4189-4195
[3]   Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: Influence on muscle glycogen synthase and insulin receptor kinase activity [J].
Breum, L ;
Bjerre, U ;
Bak, JF ;
Jacobsen, S ;
Astrup, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (12) :1570-1576
[4]   K+ channels as targets for specific immunomodulation [J].
Chandy, KG ;
Wulff, H ;
Beeton, C ;
Pennington, M ;
Gutman, GA ;
Cahalan, MD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (05) :280-289
[5]  
Choi JS, 1999, J PHARMACOL EXP THER, V291, P1
[6]   Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance [J].
Dal Ponte, DB ;
Fogt, DL ;
Jacob, S ;
Henriksen, EJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (08) :982-987
[7]   Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels [J].
Delpon, E ;
Valenzuela, C ;
Gay, P ;
Franqueza, L ;
Snyders, DJ ;
Tamargo, J .
CARDIOVASCULAR RESEARCH, 1997, 35 (02) :341-350
[8]   Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle [J].
Eto, K ;
Ohya, Y ;
Nakamura, Y ;
Abe, I ;
Fujishima, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 423 (01) :1-7
[9]  
Izumi T, 1996, J PHARMACOL EXP THER, V277, P1630
[10]   Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes [J].
Knock, GA ;
Mishra, SK ;
Aaronson, PI .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 368 (01) :103-109